Utility and willingness to pay measurements among patients with gastroesophageal reflux disease.
Kartman
B
B
Health Economics, AstraZeneca R & D, Mölndal, Sweden.
D001294:Attitude to Health; D003362:Cost-Benefit Analysis; D005764:Gastroesophageal Reflux / Q000191:economics*; D006801:Humans; D019057:Quality-Adjusted Life Years